News
On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its ...
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
1d
Zacks Investment Research on MSNHere's Why United Therapeutics (UTHR) is a Strong Value StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
1d
Zacks Investment Research on MSNBrokers Suggest Investing in Lilly (LLY): Read This Before Placing a BetThe recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
It’s time we stop creating work that holds up a mirror to what’s broken and start imagining creative solutions that inspire a ...
Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...
Company touted Kisqali's "replacement power" as another blockbuster faces generic competition and expressed optimism about ...
Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
Eli Lilly’s stock closed at $771.75, slipping 3.45% and lagging the broader market. The company’s shares fell despite ...
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
This week, Phil Oakley has analysed two shares, DexCom (US:DXCM) and Auto Trader (AUTO), which have decent earnings growth forecasts but rich valuations. It looks like both companies will need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results